O. Wayne Isom, MD – Terry Allen Kramer Professor and Chairman, Department of Cardiothoracic Surgery and Co-Director, The Howard Gilman Institute for Heart Valve Disease, Weill Medical College.
Bubble Carabello, MD – The WA Tex and Deborah Moncrief Jr. Professor of Medicine, Baylor College of Medicine, Vice Chairman, Department of Medicine, Baylor College of Medicine.The results of of this study will used to help in selecting a dose for the further evaluation a clinical study performed in adults age 65 and earlier of this year and in a subsequent III study III clinical study. – Enrollment of said second Phase II trial another significant milestone in the development of our VLP seasonal influenza vaccine Programme constitutes, said Dr. Rahul Singhvi, President & CEO of Novavax. This study provides the opportunity to assess the safety and immunogenicity of the VLP vaccine for a new set of strains of influenza, to further strengthen our growing clinical data base for VLP-based influenza vaccine. The completion of the enrollment holds us on the right way to a top online data for the 2008-2009 vaccine during the third quarter this year and selecting a dose for a phase II trials seen in older adults later in the year.